Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B infection. It contains hepatitis B surface antigen (rdna) and is administered intramuscularly or subcutaneously. This vaccine is suitable for individuals at risk of hepatitis B.

Engerix-B is used to protect against hepatitis B, a viral infection that can cause serious liver damage. It is often recommended for individuals who are at higher risk of exposure, such as healthcare workers, travelers to regions with high infection rates, and those with certain medical conditions. The vaccine works by stimulating the body's immune response to develop protection against the hepatitis B virus.

Common effects of Engerix-B may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or low-grade fever. These effects are generally mild and short-lived, indicating that the body is responding to the vaccine.

Engerix-B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or medications. Pregnant or breastfeeding individuals should consult a healthcare provider before receiving the vaccine.

Engerix-B may interact with certain medications or other vaccines. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Alcohol and other substances that weaken the immune system might affect the vaccine's effectiveness.